These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates. Franssen EJ; Koiter J; Kuipers CA; Bruins AP; Moolenaar F; de Zeeuw D; Kruizinga WH; Kellogg RM; Meijer DK J Med Chem; 1992 Apr; 35(7):1246-59. PubMed ID: 1560438 [TBL] [Abstract][Full Text] [Related]
7. Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats. Duncan R; Seymour LC; Scarlett L; Lloyd JB; Rejmanová P; Kopecek J Biochim Biophys Acta; 1986 Jan; 880(1):62-71. PubMed ID: 3942780 [TBL] [Abstract][Full Text] [Related]
8. Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates. Kasuya Y; Lu ZR; Kopecková P; Tabibi SE; Kopecek J Pharm Res; 2002 Feb; 19(2):115-23. PubMed ID: 11883637 [TBL] [Abstract][Full Text] [Related]
9. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994 [TBL] [Abstract][Full Text] [Related]
10. Enzymatic cleavage of the epsilon-peptide bond in alpha- and epsilon-substituted glycyl- and phenylalanyl-lysine peptides. Plessing A; Siebert G; Wissler JH; Puigserver AJ; Pfaender P Hoppe Seylers Z Physiol Chem; 1982 Mar; 363(3):279-93. PubMed ID: 6804347 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors. Wang D; Pechar M; Li W; Kopecková P; Brömme D; Kopecek J Biochemistry; 2002 Jul; 41(28):8849-59. PubMed ID: 12102627 [TBL] [Abstract][Full Text] [Related]
12. A novel peptide delivery system involving peptidase activated prodrugs as antimicrobial agents. Synthesis and biological activity of peptidyl derivatives of 5-fluorouracil. Kingsbury WD; Boehm JC; Mehta RJ; Grappel SF; Gilvarg C J Med Chem; 1984 Nov; 27(11):1447-51. PubMed ID: 6387121 [TBL] [Abstract][Full Text] [Related]
14. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512 [TBL] [Abstract][Full Text] [Related]
15. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer. Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367 [TBL] [Abstract][Full Text] [Related]
16. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination. Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433 [TBL] [Abstract][Full Text] [Related]
17. Increased resistance of peptides to serum proteases by modification of their amino groups. Galati R; Verdina A; Falasca G; Chersi A Z Naturforsch C J Biosci; 2003; 58(7-8):558-61. PubMed ID: 12939044 [TBL] [Abstract][Full Text] [Related]
18. Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil. Jolimaître P; Malet-Martino M; Martino R Int J Pharm; 2003 Jun; 259(1-2):181-92. PubMed ID: 12787646 [TBL] [Abstract][Full Text] [Related]
19. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. Etrych T; Jelínková M; Ríhová B; Ulbrich K J Control Release; 2001 May; 73(1):89-102. PubMed ID: 11337062 [TBL] [Abstract][Full Text] [Related]